The demand for State-of-the-art therapeutics and new drug modalities is expected to explode in the coming decade. For example, greater than two,000 gene therapies and modified cell therapies are currently underneath advancement, in conjunction with 800-furthermore non-genetically modified mobile therapies, according to the American Society of Gene